National Patterns of Care and Outcomes After Combined Modality Therapy for Stage IIIA Non–Small-Cell Lung Cancer-Reference-Cited by-同舟云学术

National Patterns of Care and Outcomes After Combined Modality Therapy for Stage IIIA Non–Small-Cell Lung Cancer

Published:2014-05 Issue:5 Volume:9 Page:612-621
ISSN:1556-0864
Container-title:Journal of Thoracic Oncology
language:en
Short-container-title:Journal of Thoracic Oncology

Author:

Patel Aalok P.,Crabtree Traves D.,Bell Jennifer M.,Guthrie Tracey J.,Robinson Clifford G.,Morgensztern Daniel,Colditz Graham A.,Kreisel Daniel,Krupnick A. Sasha,Bradley Jeffrey D.,Patterson G. Alexander,Meyers Bryan F.,Puri Varun

Publisher

Elsevier BV

Subject

Pulmonary and Respiratory Medicine,Oncology

Reference31 articles.

1. Cancer statistics, 2012;Siegel;CA Cancer J Clin,2012

2. Prognostic significance of tumor size in patients with stage III non-small-cell lung cancer: a surveillance, epidemiology, and end results (SEER) survey from 1998 to 2003;Morgensztern;J Thorac Oncol,2012

3. The IASLC Lung Cancer Staging Project: Validation of the Proposals for Revision of the T, N, and M Descriptors and Consequent Stage Groupings in the Forthcoming (Seventh) Edition of the TNM Classification of Malignant Tumours

4. New radiotherapy and chemoradiotherapy approaches for non-small-cell lung cancer;Salama;J Clin Oncol,2013

5. A randomized phase III comparison of standard-dose (60 Gy) versus high-dose (74 Gy) conformal chemoradiotherapy with or without cetuximab for stage III non-small cell lung cancer: Results on radiation dose in RTOG 0617;Bradley;ASCO Meeting Abstracts,2013

Cited by 30 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Regional differences in epidermal growth factor receptor-tyrosine kinase inhibitor therapy in lung cancer treatment using a national database in Japan;Scientific Reports;2023-03-30

2. Surgical decision-making in advanced-stage non–small cell lung cancer is influenced by more than just guidelines;JTCVS Open;2022-09

3. Effectiveness of durvalumab consolidation in stage III non-small-cell lung cancer: focus on treatment selection and prognostic factors;Immunotherapy;2022-08

4. Select octogenarians with stage IIIa non–small cell lung cancer can benefit from trimodality therapy;JTCVS Open;2022-06

5. Early-Stage Non-Small Cell Lung Cancer Stereotactic Body Radiation Therapy (SBRT) Outcomes in an Equal Access Military Setting;Cureus;2021-02-22